X0306 4 2022-11-16 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001192591 HOMCY CHARLES J C/O BRIDGEBIO PHARMA, INC. 421 KIPLING ST. PALO ALTO CA 94301 1 0 0 0 Common Stock 2022-11-16 4 M 0 3760 A 1215552 D Common Stock 2022-11-16 4 F 0 1301 9.64 D 1214251 D Restricted Stock Units 2022-11-16 4 M 0 3760 0.00 D Common Stock 3760 18799 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Includes 840 shares acquired on February 17, 2021 and 1,497 shares acquired on August 15, 2022 by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,760 shares of Common Stock underlying the Reporting Person's RSUs. The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. /s/ Brian C. Stephenson, Attorney-in-Fact 2022-11-18